↓ Skip to main content

Dove Medical Press

The Double Burden of the COVID-19 Pandemic and Polypharmacy on Geriatric Population – Public Health Implications

Overview of attention for article published in Therapeutics and Clinical Risk Management, October 2020
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (80th percentile)
  • Good Attention Score compared to outputs of the same age and source (69th percentile)

Mentioned by

news
1 news outlet
twitter
2 X users

Readers on

mendeley
273 Mendeley
Title
The Double Burden of the COVID-19 Pandemic and Polypharmacy on Geriatric Population – Public Health Implications
Published in
Therapeutics and Clinical Risk Management, October 2020
DOI 10.2147/tcrm.s272908
Pubmed ID
Authors

Sayeeda Rahman, Keerti Singh, Sameer Dhingra, Jaykaran Charan, Paras Sharma, Salequl Islam, Dilshad Jahan, Katia Iskandar, Nandeeta Samad, Mainul Haque

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 273 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 273 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 33 12%
Student > Master 29 11%
Researcher 22 8%
Student > Ph. D. Student 22 8%
Other 16 6%
Other 39 14%
Unknown 112 41%
Readers by discipline Count As %
Medicine and Dentistry 47 17%
Nursing and Health Professions 29 11%
Pharmacology, Toxicology and Pharmaceutical Science 18 7%
Social Sciences 11 4%
Psychology 7 3%
Other 39 14%
Unknown 122 45%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 October 2022.
All research outputs
#3,276,958
of 25,387,668 outputs
Outputs from Therapeutics and Clinical Risk Management
#155
of 1,323 outputs
Outputs of similar age
#82,338
of 432,252 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#4
of 13 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,323 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has done well, scoring higher than 88% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 432,252 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 13 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.